Table 4 Provider assessed toxicity (CTCAE V.5)
| Â | Any grade toxicity | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
Skin dermatitis | 86.3% (19) | 50.0% (11) | 31.9% (7) | 4.5% (1) |
Mucositis | 90.1% (20) | 45.5% (10) | 50.0% (11) | 4.5% (1) |
Dysgeusia | 90.1% (20) | 45.5% (10) | 40.1% (9) | 4.5% (1) |
Dysphagia | 100% (22) | 22.7% (5) | 72.7% (16) | 9.1% (2) |
Acute xerostomia | 63.6% (14) | 54.5% (12) | 9.1% (2) | 0 |
Xerostomia > 3 m | 36.3% (8) | 22.7% (5) | 13.6% (3) | 0 |
Dysphagia > 3 m | 27.3% (6) | 13.6% (3) | 9.1% (2) | 4.5% (1) |
Fibrosis > 6 m | 9.1% (2) | 9.1% (2) | 0 | 0 |